Traders Purchase Large Volume of Call Options on Aetna (AET)

Aetna Inc (NYSE:AET) saw unusually large options trading activity on Thursday. Stock traders bought 16,802 call options on the company. This represents an increase of 1,130% compared to the average daily volume of 1,366 call options.

Shares of Aetna (NYSE:AET) opened at $176.39 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 1.68. Aetna has a 12 month low of $121.01 and a 12 month high of $194.40. The company has a market cap of $57,000.00, a P/E ratio of 30.68, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 EPS for the quarter, beating the consensus estimate of $1.18 by $0.07. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The business had revenue of $14.74 billion during the quarter, compared to analysts’ expectations of $14.79 billion. During the same period in the previous year, the business posted $0.08 EPS. The business’s quarterly revenue was down 6.2% compared to the same quarter last year. equities research analysts predict that Aetna will post 10.99 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Thursday, January 11th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.13%. The ex-dividend date was Wednesday, January 10th. Aetna’s payout ratio is 34.78%.

A number of analysts recently commented on AET shares. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Piper Jaffray Companies upgraded shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 target price for the company in a research note on Wednesday, January 3rd. Argus cut shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price for the company. in a research note on Wednesday, December 6th. Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price for the company. in a research note on Wednesday, December 20th. Finally, Jefferies Group lifted their target price on shares of Aetna from $165.00 to $185.00 and gave the stock a “hold” rating in a research note on Wednesday, November 1st. Ten equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Aetna has a consensus rating of “Buy” and an average price target of $185.94.

A number of hedge funds and other institutional investors have recently made changes to their positions in AET. Alpine Associates Management Inc. acquired a new stake in Aetna during the 4th quarter valued at approximately $159,933,000. Orbimed Advisors LLC lifted its stake in Aetna by 57.3% during the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock valued at $222,057,000 after acquiring an additional 508,600 shares during the period. CI Investments Inc. acquired a new position in shares of Aetna in the 4th quarter valued at $87,552,000. Governors Lane LP acquired a new position in shares of Aetna in the 4th quarter valued at $68,223,000. Finally, Point72 Asset Management L.P. lifted its stake in shares of Aetna by 233.9% in the 3rd quarter. Point72 Asset Management L.P. now owns 429,353 shares of the company’s stock valued at $68,271,000 after purchasing an additional 300,753 shares during the period. Institutional investors and hedge funds own 87.41% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/02/11/traders-purchase-large-volume-of-call-options-on-aetna-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply